OTC Markets OTCQB - Delayed Quote USD

CV Sciences, Inc. (CVSI)

0.0389

+0.0015

+(4.01%)

At close: 2:48:47 PM EST

CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced that it has entered into a definitive agreement (the "Purchase Agreement") to acquire Extract Labs, Inc. ("Extract Labs"), a leading manufacturer and distributor of premium cannabinoid products including gummies, topicals and tinctures. Extract Labs branded produc

PR Newswire 2 months ago

CVSI
+4.01%
CV Sciences, Inc. Reports Third Quarter 2024 Financial Results

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended September 30, 2024.

PR Newswire 2 months ago

CVSI
+4.01%
CV Sciences, Inc. To Announce Third Quarter 2024 Results On November 14, 2024

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the third quarter ended September 30, 2024, before the stock market opens on Thursday, November 14, 2024. The Company will hold a conference call with the investment community at 7:00 a.m. Pacific Time (10:00 a.m. Eastern

PR Newswire 2 months ago

CVSI
+4.01%
CV Sciences Launches +PlusHLTH, a New Line of Cannabinoid-Free Supplements

CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced the launch of +PlusHLTH™, an all-new line of cannabinoid-free supplements delivering targeted formulations for optimized health, improved performance, and increased vitality. Rooted in rigorous science and fortified by clinically proven wellness ingredients, the

PR Newswire 4 months ago

CVSI
+4.01%
CV Sciences, Inc. Reports Second Quarter 2024 Financial Results

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended June 30, 2024.

PR Newswire 5 months ago

CVSI
+4.01%
CV Sciences, Inc. To Announce Second Quarter 2024 Results On August 13, 2024

CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the second quarter ended June 30, 2024, before the stock market opens on Tuesday, August 13, 2024. The Company will hold a conference call with the investment community at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time)

PR Newswire 5 months ago

CVSI
+4.01%
CV Sciences, Inc. Reports First Quarter 2024 Financial Results

CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended March 31, 2024.

PR Newswire 8 months ago

CVSI
+4.01%
CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced that it has consummated its purchase of Elevated Softgels, LLC ("Elevated Softgels"), a leading manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry. Elevated Softgels has operational flexibility allowing low to large minim

PR Newswire 8 months ago

CVSI
+4.01%
CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the first quarter ended March 31, 2024, before the stock market opens on Tuesday, May 14, 2024. The Company will hold a conference call with the investment community at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time) tha

PR Newswire 8 months ago

CVSI
+4.01%
CV Sciences, Inc. (PNK:CVSI) Q4 2023 Earnings Call Transcript

CV Sciences, Inc. (PNK:CVSI) Q4 2023 Earnings Call Transcript March 28, 2024 CV Sciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to CV Sciences’ Fourth Quarter and Year-End 2023 Conference. At this time, all participants are […]

Insider Monkey 9 months ago

CVSI
+4.01%
CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the year and quarter ended December 31, 2023.

PR Newswire 9 months ago

CVSI
+4.01%
CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews

CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, proudly announces its latest innovation and product launch: a premier CBD chew tailored for pets, +PlusCBD™ Pet Hip and Joint Health Chews and +PlusCBD™ Pet Calming Care Chews. +PlusCBD™Pet wellness treats are crafted with the utmost care and supported by extensive research, and

PR Newswire 9 months ago

CVSI
+4.01%
CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024

CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in nutraceuticals and plant-based foods, today announced that it will release financial results for the year and fourth quarter ended December 31, 2023, before the stock market opens on Thursday, March 28, 2024. The Company will hold a conference call with the investment community at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time) that same day.

PR Newswire 9 months ago

CVSI
+4.01%

Performance Overview

Return	CVSI	S&P 500
YTD	+29.67%	+3.29%
1-Year	-2.75%	+25.42%
3-Year	-72.21%	+38.73%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

CV Sciences, Inc. (CVSI)

CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs

CV Sciences, Inc. Reports Third Quarter 2024 Financial Results

CV Sciences, Inc. To Announce Third Quarter 2024 Results On November 14, 2024

CV Sciences Launches +PlusHLTH, a New Line of Cannabinoid-Free Supplements

CV Sciences, Inc. Reports Second Quarter 2024 Financial Results

CV Sciences, Inc. To Announce Second Quarter 2024 Results On August 13, 2024

CV Sciences, Inc. Reports First Quarter 2024 Financial Results

CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER

CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024

CV Sciences, Inc. (PNK:CVSI) Q4 2023 Earnings Call Transcript

CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results

CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews

CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024

Performance Overview